CLDI Stock Analysis: Buy, Sell, or Hold?
CLDI - Calidi Biotherapeutics, Inc.
$0.16
0.01 (5.53%)
▲
5d:
-7.37%
30d:
-14.64%
90d:
-49.97%
HOLD
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CLDI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLDI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLDI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLDI is currently trading at $0.16, which is considered oversold relative to its 30-day fair value range of $0.17 to $0.20.
Technical Outlook: Technically, CLDI is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.19. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $120.00 (+73931.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLDI is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.19. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $120.00 (+73931.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.17 -
$0.20
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.5%)
- BULLISH: Trading 73931.3% below Wall St target ($120.00)
- CAUTION: Recommendation downgraded due to -7.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.17 -
$0.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.12
Resistance Level
$0.19
Current Trend
Strong Downtrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.03
Wall Street Target
$120.00
(+73931.3%)
Share & Embed Analysis
Last updated: June 15, 2026 9:02 PM ET
Data refreshes hourly during market hours. Next update: 10:02 PM
Data refreshes hourly during market hours. Next update: 10:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$256 | 59 HOLD |
